Radiofrequency Ablation vs. Cryoablation for Localized Hepatocellular Carcinoma: A Propensity-matched Population Study

Background/Aim: To compare overall survival (OS) and liver cancer-specific survival (LCSS) of Surveillance, Epidemiology and End Results (SEER) hepatocellular carcinoma (HCC) database patients treated with cryoablation (cryo) or radiofrequency ablation (RFA). Materials and Methods: This was a retrospective review of Stage I or II HCC patients from the SEER database treated with cryo and RFA from 2004-2013. Kaplan–Meier and Cox regressions were performed on pooled and propensity-matched cohort. Results: Out of 3,239 patients, RFA showed a significant survival advantage over cryo in liver cancer specific survival (LCSS) (HR=1.634 p=0.0004). A total of 91 propensity-matched pairs had similar OS (HR=1.006 p=0.9768), but no difference in LCSS was observed between the groups [HR=1.412 (95%CI=0.933-2.137) p=0.1023]. Survival Cox models did not reveal treatment type as an independent prognostic factor. Conclusion: Propensity-matched cohort showed no significant difference in terms of OS and LCSS was found for patients treated with either cryo or RFA for localized HCC.

[1]  W. Jeong,et al.  Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis , 2016, Clinical and molecular hepatology.

[2]  Yingying Ding,et al.  Cryoablation Versus Radiofrequency Ablation for Hepatic Malignancies , 2015, Medicine.

[3]  Yinying Lu,et al.  Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma , 2015, Hepatology.

[4]  T. Hibi,et al.  Cryoablation Provides Superior Local Control of Primary Hepatocellular Carcinomas of >2 cm Compared with Radiofrequency Ablation and Microwave Coagulation Therapy: An Underestimated Tool in the Toolbox , 2015, Annals of Surgical Oncology.

[5]  J. Hinshaw,et al.  Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? , 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

[6]  Li-Zhi Niu,et al.  Percutaneous Cryoablation for Liver Cancer , 2014, Journal of clinical and translational hepatology.

[7]  V. Saraswat,et al.  Treatment algorithms for managing hepatocellular carcinoma. , 2014, Journal of clinical and experimental hepatology.

[8]  Jae Young Lee,et al.  Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. , 2014, Radiology.

[9]  F. Piscaglia,et al.  Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. , 2013, World journal of gastroenterology.

[10]  Yinying Lu,et al.  Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma , 2011, Journal of hepato-biliary-pancreatic sciences.

[11]  D. Gervais,et al.  Percutaneous tumor ablation for hepatocellular carcinoma. , 2011, AJR. American journal of roentgenology.

[12]  P. Austin.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[13]  Yong Zeng,et al.  A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria , 2010, Annals of surgery.

[14]  Shota Yamamoto,et al.  Percutaneous ablation of hepatocellular carcinoma: current status. , 2010, Journal of vascular and interventional radiology : JVIR.

[15]  E. Vicaut,et al.  Radiofrequency ablation of hepatocellular carcinoma: Long‐term results and prognostic factors in 235 Western patients with cirrhosis , 2009, Hepatology.

[16]  Qiang Zhou,et al.  Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. , 2009, World journal of gastroenterology.

[17]  Y. Kodama,et al.  Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma. , 2009, Journal of hepato-biliary-pancreatic surgery.

[18]  M. Choi,et al.  Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series , 2007, European Radiology.

[19]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[20]  Shinpei Sato,et al.  Percutaneous radiofrequency ablation for hepatocellular carcinoma , 2005, Cancer.

[21]  Carlo Bartolozzi,et al.  Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. , 2005, Radiology.

[22]  Carlo Bartolozzi,et al.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. , 2003, Radiology.

[23]  H. Bismuth,et al.  A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. , 2002, Archives of surgery.

[24]  D. Allegra,et al.  Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. , 2000, Archives of surgery.

[25]  L Solbiati,et al.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.

[26]  Xin-da Zhou,et al.  Cryotherapy for primary liver cancer. , 1998, Seminars in surgical oncology.

[27]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[28]  W. Lau,et al.  Ultrasound-guided percutaneous cryotherapy of hepatocellular carcinoma. , 2011, International journal of surgery.

[29]  Yinying Lu,et al.  Efficacy of argon-helium cryosurgical ablation on primary hepatocellular carcinoma: a pilot clinical study. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.

[30]  Marcelo Coca-Perraillon.  Local and Global Optimal Propensity Score Matching , 2007 .